Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein

Biochemical and Biophysical Research Communications

Volumn 313, Issue 4, 2004, Pages 938-947

  Ho, Tin Yun ^a   Wu, Shih Lu ^a   Cheng, Shin Ei ^a   Wei, Yen Chiao ^a   Huang, Shan Ping ^a   Hsiang, Chien Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antigenicity; Coronavirus; Expression; Receptor binding; SARS; Spike

Indexed keywords

BIOTIN; ISOPROPYL BETA DEXTRO THIOGALACTOSIDE; PROTEIN; PROTEIN P130; PROTEIN P140; RECOMBINANT PROTEIN; SARS CORONAVIRUS SPIKE PROTEIN; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; STRUCTURAL PROTEIN; THIOGLYCOSIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; VIRUS VACCINE; VIRUS VECTOR; VITRONECTIN;

AFFINITY CHROMATOGRAPHY; ANTIGENICITY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR BINDING; RNA VIRUS; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS RECOMBINANT; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); CORONAVIRUS; ESCHERICHIA COLI; RNA VIRUSES; SARS CORONAVIRUS; VECTORS;

EID: 0346098157     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.180     Document Type: Article

References (26)

1. WHO, Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS), www.who.int/csr/sars/country/table2003_09_23/en/ (accessed September 23, 2003).
2. Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J.J., van den Hoogen B.G., Peiris M., Lim W., Stohr K., Osterhaus A.D.M.E. Koch's postulates fulfilled for SARS virus. Nature. 423:2003;240.
3. T.G. Ksiazek, D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, J.A. Comer, W. Lim, P.E. Rollin, S.F. Dowell, A. Ling, C.D. Humphrey, W. Shieh, J. Guarner, C.D. Paddock, P. Rota, B. Fields, J. DeRisi, J. Yang, N. Cox, J.M. Hughes, J.W. LeDuc, W.J. Bellini, L.J. Anderson, the SARS working group, A novel coronavirus associated with severe acute respiratory syndrome, N. Engl. J. Med. 348 (2003) 1953-1966.
4. J.S.M. Peiris, S.T. Lai, L.L.M. Poon, Y. Guan, L.Y.C. Yam, W. Lim, J. Nicholls, W.K.S. Yee, W.W. Yan, M.T. Cheung, V.C.C. Cheng, K.H. Chan, D.N.S. Tsang, R.W.H. Yung, T.K. Ng, K.Y. Yuen, members of the SARS study group, Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet 361 (2003) 1319-1325.
5. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300:2003;1394-1399.
6. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., Roper R.L. The Genome sequence of the SARS-associated coronavirus. Science. 300:2003;1399-1404.
7. Lai M.M.C., Holmes K.V. Coronaviridae: the viruses and their replication. Knipe D.M., Howley P.M., Griffin D.E., Martin M.A., Lamb R.A., Roizman B. Field's Virology. 2001;1163-1186 Lippincott Williams and Wilkins, Philadelphia.
8. Oleszak E.L., Perlman S., Leibowitz J.L. MHV S peplomer protein expressed by a recombinant vaccinia virus vector exhibits IgG Fc-receptor activity. Virology. 186:1992;122-132.
9. Delmas B., Gelfi J., Sjostrom H., Noren O., Laude H. Further characterization of aminopeptidase-N as a receptor for coronaviruses. Adv. Exp. Med. Biol. 342:1993;293-298.
10. Schmidt I., Skinner M., Siddell S. Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM. J. Gen. Virol. 68:1987;47-56.
11. de Groot R.J., van Leen R.W., Dalderup M.J.M., Vennema H., Horzinek M.C., Spaan W.J. Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. Virology. 171:1989;493-502.
12. Godet M., Grosclaude J., Delmas B., Laude H. Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J. Virol. 68:1994;8008-8016.
13. Collins A.R., Knobler R.L., Powell H., Buchmeier M.J. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 119:1982;358-371.
14. Fleming J.O., Stohlman S.A., Harmon R.C., Lai M.M., Frelinger J.A., Weiner L.P. Antigenic relationship of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology. 131:1983;296-307.
15. Fazakerley J.K., Parker S.E., Bloom F., Buchmeier M.J. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 187:1992;178-188.
16. Leparc-Goffart I., Hingley S.T., Chua M.M., Phillips J., Lavi E., Weiss S.R. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J. Virol. 72:1998;9628-9636.
17. Sanchez C.M., Izeta A., Sanchez-Morgado J.M., Alonso S., Sola I., Balasch M., Plana-Duran J., Enjuanes L. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J. Virol. 73:1999;7607-7618.
18. Hsiang C.Y., Ho T.Y., Hsiang C.H., Chang T.J. Recombinant pseudorabies virus DNase exhibits a RecBCD-like catalytic function. Biochem. J. 330:1998;55-59.
19. Yu X., Luo C., Lin J., Hao P., He Y., Guo Z., Qin L., Su J., Liu B., Huang Y., Nan P., Li C., Xiong B., Luo X., Zhao G., Pei G., Chen K., Shen X., Shen J., Zou J., He W., Shi T., Zhong Y., Jiang H., Li Y. Putative hAPN receptor binding sites in SARS-CoV spike protein. Acta Pharmacol. Sin. 24:2003;481-488.
20. Mechin M., der Vartanian M., Martin C. The major subunit C1pG of Escherichia coli CS31A fibrillae as an expression vector for different combinations of two TGEV coronavirus epitopes. Gene. 179:1996;211-218.
21. Smerdou C., Anton I.M., Plana J., Curtiss R., Enjuanes L. A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. Virus Res. 41:1996;1-9.
22. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132.
23. Emini E.A., Hughes J.V., Perlow D.S., Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J. Virol. 55:1985;836-839.
24. Karplus P.A., Schulz G.E. Prediction of chain flexibility in proteins. A tool for the selection of peptide antigens. Naturwissenschaften. 72:1985;212-213.
25. Townsend A., Rothbard J., Gotch F.M., Bahadur G., Wraith D., McMichael A.J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44:1986;959-968.
26. Geysen H.M., Rodda S.J., Mason T.J., Tribbick G., Schoofs P.G. Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods. 102:1987;259-274.